|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/28 | |
| A61K 31/00 | |||
| A61P 9/04 | |||
| A61K 9/20 |
| (11) | Patento numeris | 2968180 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14715519.6 |
| Europos patento paraiškos padavimo data | 2014-03-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-04-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/027061 |
| Data | 2014-03-14 |
| (87) | Numeris | WO 2014/152198 |
| Data | 2014-09-25 |
| (30) | Numeris | Data | Šalis |
| 201361785492 P | 2013-03-14 | US |
| (72) |
CALDWELL, Brett, US
|
| (73) |
Amgen Inc.,
1 Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | HETEROCYCLIC COMPOUNDS AND THEIR USES |
| HETEROCYCLIC COMPOUNDS AND THEIR USES |